A. YERLİKAYA And E. Kanbur, "The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells," CURRENT DRUG TARGETS , vol.21, no.13, pp.1313-1325, 2020
YERLİKAYA, A. And Kanbur, E. 2020. The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells. CURRENT DRUG TARGETS , vol.21, no.13 , 1313-1325.
YERLİKAYA, A., & Kanbur, E., (2020). The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells. CURRENT DRUG TARGETS , vol.21, no.13, 1313-1325.
YERLİKAYA, AZMİ, And Ertan Kanbur. "The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells," CURRENT DRUG TARGETS , vol.21, no.13, 1313-1325, 2020
YERLİKAYA, AZMİ And Kanbur, Ertan. "The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells." CURRENT DRUG TARGETS , vol.21, no.13, pp.1313-1325, 2020
YERLİKAYA, A. And Kanbur, E. (2020) . "The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells." CURRENT DRUG TARGETS , vol.21, no.13, pp.1313-1325.
@article{article, author={AZMİ YERLİKAYA And author={Ertan Kanbur}, title={The Ubiquitin-Proteasome Pathway and Resistance Mechanisms Developed Against the Proteasomal Inhibitors in Cancer Cells}, journal={CURRENT DRUG TARGETS}, year=2020, pages={1313-1325} }